Skip to main content

Michael Drues

Nov 13, 2026

5:27
And we can talk about sample size or double blind or some of the technical aspects of how do you design the trial when you're dealing with a medical device.
5:41
I'm happy to address all of those points, Jesus, but let me get to those in just a moment.
5:48
I just want to share a couple more pieces of advice with regard to your first question, another of the very, very significant differences.
5:57
between medical devices versus drugs, perhaps from a regulatory perspective, the single most significant difference is where we set the bar in terms of safety and efficacy.
6:08
In other words, in the drug world, as probably many of your audience knows, we require substantial evidence of safety and efficacy.
6:18
Whereas in the medical device world, we require reasonable evidence of safety and efficacy.
6:24
Now, if you – I don't mean you personally, but if people think that the only difference between substantial versus reasonable is semantics, they really do not understand the world in which we live, quite frankly.

36 MINS LATER

42:08
And that is, how can a clinical team structure the data gathering in such a way that it maximizes clinical insight without over committing to a rigorous endpoint that could backfire during a pivotal trial further down the line.
23:02
What about the under construction list?
23:04
Yeah, so once again, and I can't emphasize this point enough, in my view, all guidance, indeed all regulation, including the Code of Federal Regulations, is under construction.
23:16
It's constantly evolving.
23:17
It's constantly changing.
23:19
And I would think, Eddie, and that you as well as most people would probably agree with me on that.
23:24
We don't want regulation that we write it down today, and it will never change for a million years.
23:30
I mean, I would not want to live in that kind of a world.

10 MINS LATER

33:45
Sure.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.